Panel of 88 SNPs Predicts Breast CA Risk in Women at High Risk

Share this content:
Panel of 88 SNPs Predicts Breast CA Risk in Women at High Risk
Panel of 88 SNPs Predicts Breast CA Risk in Women at High Risk

FRIDAY, Dec. 30, 2016 (HealthDay News) -- A panel of 88 single nucleotide polymorphisms (SNPs) can predict breast cancer risk, according to a study published online Dec. 28 in the Journal of Clinical Oncology.

Jack Cuzick, Ph.D., from the Queen Mary University of London , and colleagues examined a risk score on the basis of 88 SNPs (SNP88) in a nested case-control study of women enrolled in the International Breast Intervention Study or the Royal Marsden study. Three hundred fifty-nine women who developed cancer were matched to 636 controls by age, trial, follow-up time, and treatment arm. Matched concordance indices were used to assess performance of SNP88 alone and with other breast cancer risk factors assessed using the Tyrer-Cuzick (TC) model.

The researchers found that SNP88 predicted breast cancer risk overall (interquartile range odds ratio [IQ-OR], 1.37), primarily for estrogen receptor-positive disease versus estrogen receptor-negative disease (IQ-OR, 1.44). For SNP88, the observed risk was 46 percent of expected. There was no significant interaction for treatment arm (P for heterogeneity = 0.5). The predictive power was similar to that of the TC model (IQ-OR, 1.45); SNP88 was found to be independent of TC (P = 0.7). There was a substantial improvement when SNP88 and TC were combined multiplicatively (IQ-OR, 1.64).

"A polygenic risk score may be used to refine risk from the TC or similar models in women who are at an elevated risk of breast cancer and considering preventive therapy," the authors write.

Several authors disclosed financial ties to the biopharmaceutical industry; two authors disclosed royalty payments for commercial use of the Tyrer-Cuzick algorithm.

Full Text
Editorial

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease



Sign up for myCME e-newsletters




More in Home

FDA Approves First Generic Under-the-Tongue Suboxone

FDA Approves First Generic Under-the-Tongue Suboxone

May only be prescribed by Drug Addiction Treatment Act-certified prescribers

Kellogg's Honey Smacks Cereal Recalled Due to Salmonella Risk

Kellogg's Honey Smacks Cereal Recalled Due to <i>Salmonella</i> ...

Twenty-four people have been hospitalized, but no deaths have been reported

Portable Music Player Use Linked to Hearing Loss in Children

Portable Music Player Use Linked to Hearing Loss ...

Increased odds of high-frequency hearing loss with portable music player use

is free, fast, and customized just for you!




Already a member?

Sign In Now »